Member Info for solstace

Dont be so daft! Bottoms 80pps with so'much news due it will bounce up apart from the odd MM shake!
Its a screaming buy from here! GLA

https://www.theguardian.com/world/live/2020/jul/12/coronavirus-live-news-australia-vaccine-human-trials-to-start-trump-wears-mask-in-public

Goes out tomorrow! Could move fast, bottom hit huge bounce due. GLA

Sam they don't need to change the software the Genedrive software is an upgrade that's all its not required to run the test! Current platforms will work

Started and we have a better product backed up with a software package! This is going to be massive over coming weeks!

Solid update highlighting a LOT more to come!

Doris-Ann Williams
London based, United Kingdom

Joined on Apr 10, 2020

Bio Chief Executive BIVDA since 2001 Worked in IVD industry since 1978 Currently also on Longitude Prize panel, VP of Parliamentary & Scientific Committee and Trustee of UK NEQAS Chaired organising committee of STEMforBritain 2020 Former NED for EKF Diagnostics and Atomo Diagnostics

https://innovate.mygov.in/innovation/bivida/

Tom Jordan 5 hours ago

Thanks for this David, the reviewers have looked over this earlier. They found this product promising and are keen for labs to be able to review this and consider its use. I will move the idea into our "catalogue of resources" page and we will share the link to this page via a bulletin to go out this Monday.

Kind regards,
Tom
Testing Methods team

Phil sorry to say but NO ONE can tell you if they have sales or not, its price sensitive information! It will be released via RNS and through no other channels thems the rules!

RNS tomorrow or Friday, sales info will be included in the Annual trading update same kinda date every year!

In the Annual trading update!

RNS being penned now imop Annual trading update same time as last year July 9th, could aslo be Friday....

News is due in one or two days and imop will include an update on sales progress! Same time ladt yesr, so sit tight and chill out as its coming! GLA

I would think all regulatory bodies in all countries are completely swamped with 100x more products being processed than usual so lead times will be affected and in reality it could now take a month+ whereas it would have been 2 weeks prior to Covid19.

Omega is not cleared to sell in India they have not recieved regulatory approval.

Superior product enabling labs to streamline with a greater throughput and ultimately test more people! Huge market potential just as Covid19 is tragically surging globally!

The Genedrive® 96 SARS-CoV-2 Kit is a novel Polymerase Chain Reaction (PCR) assay designed to detect active
infection in COVID-19 patients. genedrive’s PCR bead format eliminatesthe need for the time consuming and errorprone reagent preparation required in all other open-platform test kits. The proprietary format streamlines
laboratory workflow, allowing more tests to be performed in a day. Patient samples are simply mixed with the PCR
beads, and are then analysed on a variety of existing third-party real time PCR platforms. During CE-IVD evaluations
on 180 randomised specimens, the Genedrive® 96 SARS-CoV-2 Kit achieved 100% sensitivity and 98.2% specificity,
placing it in a top tier performance table for COVID-19 PCR tests.

Following CE-IVD marking, the Company can commence commercial sales in the UK and across the EU immediately.
The Company will now begin distribution to potential customers for initial clinical evaluations, and aims to record
first commercial sales in June.

David Budd, Chief Executive Officer of genedrive plc, said: “The development teams at genedrive and at Cytiva
have worked tirelessly over the past 2 months to develop our unique product that has the potential to streamline
lab testing, improve quality, and ultimately allow more people to be tested. CE marking was achieved with
performance studies and validations that will also support regulatory applications in other jurisdictions, such as
Emergency Use Authorisation with the USA FDA and Emergency Use Assessment and Listing with the WHO. The
temperature stable nature of the Genedrive® 96 SARS-CoV-2 kit means we have the potential to easily access these
global markets, which are in urgent need of testing efficiency and volume

Cheers Admin! Hopefully you slapped a ban on him also.........